BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 36574946)

  • 1. Enhancement of the antitumor effect of 5-fluorouracil with modulation in drug transporters expression using PI3K inhibitors in colorectal cancer cells.
    El-Daly SM; Abo-Elfadl MT; Hussein J; Abo-Zeid MAM
    Life Sci; 2023 Feb; 315():121320. PubMed ID: 36574946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TMEM97 knockdown inhibits 5-fluorouracil resistance by regulating epithelial-mesenchymal transition and ABC transporter expression via inactivating the Akt/mTOR pathway in 5-fluorouracil-resistant colorectal cancer cells.
    Xu Y; Tang Y; Xu Q; He W
    Chem Biol Drug Des; 2024 Feb; 103(2):e14490. PubMed ID: 38388887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long noncoding RNA H19 promotes chemotherapy resistance in choriocarcinoma cells.
    Yu S; Wu C; Tan Q; Liu H
    J Cell Biochem; 2019 Sep; 120(9):15131-15144. PubMed ID: 31020694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of Smad4 in colorectal cancer induces resistance to 5-fluorouracil through activating Akt pathway.
    Zhang B; Zhang B; Chen X; Bae S; Singh K; Washington MK; Datta PK
    Br J Cancer; 2014 Feb; 110(4):946-57. PubMed ID: 24384683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anlotinib Overcomes Multiple Drug Resistant Colorectal Cancer Cells via Inactivating PI3K/AKT Pathway.
    Lan W; Zhao J; Chen W; Shang H; Peng J; Lin J
    Anticancer Agents Med Chem; 2021; 21(15):1987-1995. PubMed ID: 33438566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hydroxysafflor yellow A inhibits proliferation, migration, and chemoresistance of colorectal cancer cells through Akt/mTOR-autophagy pathway].
    Wang L; Li F; Gu NN; Shen H; Han CL; Li KY; Yan RY; Wang J; Mi ZK
    Zhongguo Zhong Yao Za Zhi; 2023 Jan; 48(2):517-524. PubMed ID: 36725241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deoxyshikonin isolated from
    Zhu Y; Zhong Y; Long X; Zhu Z; Zhou Y; Ye H; Zeng X; Zheng X
    Pharm Biol; 2019 Dec; 57(1):412-423. PubMed ID: 31230505
    [No Abstract]   [Full Text] [Related]  

  • 8. Jiedu Sangen decoction inhibits chemoresistance to 5-fluorouracil of colorectal cancer cells by suppressing glycolysis via PI3K/AKT/HIF-1α signaling pathway.
    Sun LT; Zhang LY; Shan FY; Shen MH; Ruan SM
    Chin J Nat Med; 2021 Feb; 19(2):143-152. PubMed ID: 33641785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacologic synergy between dual phosphoinositide-3-kinase and mammalian target of rapamycin inhibition and 5-fluorouracil in PIK3CA mutant gastric cancer cells.
    Bhattacharya B; Akram M; Balasubramanian I; Tam KK; Koh KX; Yee MQ; Soong R
    Cancer Biol Ther; 2012 Jan; 13(1):34-42. PubMed ID: 22336586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulation of microRNA-135b and microRNA-182 promotes chemoresistance of colorectal cancer by targeting ST6GALNAC2 via PI3K/AKT pathway.
    Liu B; Liu Y; Zhao L; Pan Y; Shan Y; Li Y; Jia L
    Mol Carcinog; 2017 Dec; 56(12):2669-2680. PubMed ID: 28767179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extract of
    Cui XL; Li KJ; Ren HX; Zhang YJ; Liu XD; Bu BG; Wang L
    World J Gastroenterol; 2019 Apr; 25(15):1854-1864. PubMed ID: 31057299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CISD2 enhances the chemosensitivity of gastric cancer through the enhancement of 5-FU-induced apoptosis and the inhibition of autophagy by AKT/mTOR pathway.
    Sun Y; Jiang Y; Huang J; Chen H; Liao Y; Yang Z
    Cancer Med; 2017 Oct; 6(10):2331-2346. PubMed ID: 28857517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Villosol reverses 5-FU resistance in colorectal cancer by inhibiting the CDKN2A gene regulated TP53-PI3K/Akt signaling axis.
    Chen H; Deng J; Hou TW; Shan YQ
    J Ethnopharmacol; 2024 May; 325():117907. PubMed ID: 38342156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual PI3K/mTOR inhibitor PF-04979064 regulates tumor growth in gastric cancer and enhances drug sensitivity of gastric cancer cells to 5-FU.
    Zhong Z; Wang T; Zang R; Zang Y; Feng Y; Yan S; Geng C; Zhu N; Wang Q
    Biomed Pharmacother; 2024 Jan; 170():116086. PubMed ID: 38159377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro and in vivo anti-colorectal cancer effect of the newly synthesized sericin/propolis/fluorouracil nanoplatform through modulation of PI3K/AKT/mTOR pathway.
    Diab SE; Tayea NA; Elwakil BH; Elshewemi SS; Gad AAEM; Abdulmalek SA; Ghareeb DA; Olama ZA
    Sci Rep; 2024 Jan; 14(1):2433. PubMed ID: 38286826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patrinia scabiosaefolia Inhibits Growth of 5-FU-Resistant Colorectal Carcinoma Cells via Induction of Apoptosis and Suppression of AKT Pathway.
    Huang SZ; Liu WY; Huang Y; Shen AL; Liu LY; Peng J
    Chin J Integr Med; 2019 Feb; 25(2):116-121. PubMed ID: 29948597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Smad4 sensitizes colorectal cancer to 5-fluorouracil through cell cycle arrest by inhibiting the PI3K/Akt/CDC2/survivin cascade.
    Zhang B; Leng C; Wu C; Zhang Z; Dou L; Luo X; Zhang B; Chen X
    Oncol Rep; 2016 Mar; 35(3):1807-15. PubMed ID: 26647806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Curcumae longae Rhizoma (Jianghuang) extract reverses the 5-Fluoruracil resistance in colorectal cancer cells via TLR4/PI3K/Akt/mTOR pathway.
    Teng Z; Sun X; Guo Y; Zhang M; Liu Y; Xu M
    Clin Res Hepatol Gastroenterol; 2022 Nov; 46(9):101976. PubMed ID: 35710041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LY294002 may overcome 5-FU resistance via down-regulation of activated p-AKT in Epstein-Barr virus-positive gastric cancer cells.
    Shin JY; Kim JO; Lee SK; Chae HS; Kang JH
    BMC Cancer; 2010 Aug; 10():425. PubMed ID: 20704765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Co-treatment with BEZ235 enhances chemosensitivity of A549/DDP cells to cisplatin via inhibition of PI3K/Akt/mTOR signaling and downregulation of ERCC1 expression.
    Xia A; Li H; Li R; Lu L; Wu X
    Oncol Rep; 2018 Oct; 40(4):2353-2362. PubMed ID: 30066933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.